mpact is the name of the p3 trial that showed adding abraxane to gemcitabine increased median survival over gemcitabine by itself. It’s published. Yes abraxane was approved in pancreatic cancer based on mpact.
mpact is the name of the p3 trial that showed adding abraxane to...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.003(4.13%) |
Mkt cap ! $15.75M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 6.1¢ | 5.8¢ | $30.32K | 507.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 57229 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.1¢ |
Change
-0.003 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.1¢ | 5.9¢ | 360164 | ||
| Last updated 14.41pm 17/05/2024 ? | |||||
| ATX (ASX) Chart |